Literature DB >> 1599922

Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.

J R Chagas1, I Y Hirata, M A Juliano, W Xiong, C Wang, J Chao, L Juliano, E S Prado.   

Abstract

The present studies demonstrate the importance of subsite interactions in determining the cleavage specificities of kallikrein gene family proteinases. The effect of substrate amino acid residues in positions P3-P'3 on the catalytic efficiency of tissue kallikreins (rat, pig, and horse) and T-kininogenase was studied using peptidyl-pNA and intramolecularly quenched fluorogenic peptides as substrates. Kinetic analyses show the different effects of D-amino acid residues at P3, Pro at P'2, and Arg at either P'1 or P'3 on the hydrolysis of substrates by tissue kallikreins from rat and from horse or pig. T-Kininogenase was shown to differ from tissue kallikrein in its interactions at subsites S2, S'1, and S'2. As a result of these differences, Abz-FRSR-EDDnp with Arg at P'2 is a good substrate for tissue kallikreins from horse, pig, and rat but not for T-kininogenase. Abz-FRRP-EDDnp and Abz-FRAPR-EDDnp with Pro at P'2 (rat high molecular weight kininogen sequence) are susceptible to rat tissue kallikrein but not to tissue kallikreins from horse and pig. Arg at P'3 increased the susceptibility of the Arg-Ala bond to rat tissue kallikrein. These data explain the release of bradykinin by rat tissue kallikrein and of kallidin by tissue kallikreins from other animal species. Abz-FRLV-EDDnp and Abz-FRLVR-EDDnp (T-kininogen sequence) are good substrates for T-kininogenase but not for tissue kallikrein. Arg at the leaving group (at either P'1, P'2, or P'3) lowers the Km values of T-kininogenase while Val at P'2 increases its kcat values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599922     DOI: 10.1021/bi00136a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.

Authors:  B A Katz; B Liu; M Barnes; E B Springman
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

2.  Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.

Authors:  F C Portaro; M H Cezari; M A Juliano; L Juliano; A R Walmsley; E S Prado
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

Authors:  D C Pimenta; J Chao; L Chao; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair phe-Phe.

Authors:  D C Pimenta; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation.

Authors:  Julie Chao; Hang Yin; Lin Gao; Makoto Hagiwara; Bo Shen; Zhi-Rong Yang; Lee Chao
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

6.  A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor.

Authors:  Lin Gao; Lee Chao; Julie Chao
Journal:  Exp Cell Res       Date:  2009-10-30       Impact factor: 3.905

7.  Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.

Authors:  Danielle G Souza; Vanessa Pinho; Jorge L Pesquero; Eliane S Lomez; Steve Poole; Luiz Juliano; Ary Correa; M Salete de A Castro; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

8.  Expression and characterization of rat kallikrein-binding protein in Escherichia coli.

Authors:  J X Ma; L Chao; G Zhou; J Chao
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

9.  Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.

Authors:  Sandro E Fogaça; Robson L Melo; Daniel C Pimenta; Kazuo Hosoi; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

10.  Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.

Authors:  E Del Nery; J R Chagas; M A Juliano; E S Prado; L Juliano
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.